JRI 

The prevalence of Chlamydia trachomatis infection by molecular analysis of urine samples in women attending OB & GYN clinics in Tehran

Vol. 7, Issue 3, / October-December 2006
(pages 234-242)

Leili Chamani Tabriz Corresponding Author
- Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
Mahmood Jeddi-Tehrani
- Monoclonal Antibody Research Center, Avicenna Research Institute (ACECR), Tehran, Iran
Alireza Mosavi-Jarrahi
- Social Medicine Department, Faculty of Medicine, Shahid Beheshti Medical Sciences University, Tehran, Iran
Hojjat Zeraati
- Epidemiology Department, Faculty of Publi Health, Tehran Medical Sciences University, Tehran, Iran
Jamileh Ghasemi
- Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
Soheila Asgari
- Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
Hodjattallah Rabbani
- Nanobiotechnology Research Center, Avicenna Research Institute (ACECR), Tehran, Iran
Mojgan Mamani
- Department of I nfectious Diseases,Hamedan University of Medical Sciences , Hamadan, Iran

Received: 10/1/2006 Accepted: 10/1/2006 - Publisher : Avicenna Research Institute

Related Articles
in Google Scholar
in PubMed

 

Other Format
pdfFull Text (En)
pdfFull Text (Fa)
pdfAbstract (En)
pdfAbstract (Fa)
pdfePUB (En)
pdfBibTeX
pdfRefMan
pdfEndNote
xmlPMC XML
online readerPMC Reader
online readerHBIs XML

 


Abstract

Introduction: Chlamydia trachomatis is a common and curable STI which can be symptomatic or asymptomatic. Nowadays, PCR is a very sensitive diagnostic tool for detecting Chlamydia in urine and can be used in routine screening procedures as a noninvasive test. There are few studies on the prevalence of C. trachomatis in Iranian women and most of them have small sample sizes which are not suitable for epidemiological deductions. The aim of this study was to estimate the prevalence of urogenital C. trachomatis infections by PCR on urine samples of women in their fertility years and to evaluate the necessity of screening for asymptomatic infections in Iranian women.Materials & Methods: This WHO supported descriptive-analytical and cross-sectional study was performed on 1052, 15-49 year-old women. Participants were selected randomly from attendees of 5 Obstetric-Gynecologic clinics in Tehran during summer and fall of 2003. The research material consisted of a questionnaire and urine samples which were transported to Avesina Research Institute daily to extract their DNA and prepare them for PCR tests. The gathered data were analyzed by SPSS, version 11, and evaluated statistically by t-test, Chi-square, variance analysis and logistic regression, while considering p<0.05 as significant.results: the mean age of participants was 28.526.36 years. 56.2% of them had high school education, 94.2% were married, 91.8% were housewives, 32.5% were pregnant, 93.8% were sexually active, 99% of them were monogamous and 48.1% were on contraceptive methods. among sexually active and non-pregnant participants, 10.4% were taking ocps, 8.7% were using condoms, 16.3% had iuds and the rest were on other contraceptive methods. in their reproductive history, 39% had vaginal discharges, 12.9% pelvic pains, 1% ectopic pregnancies, 21.2% abortions, 6.5% premature deliveries, 2.7% low birth weight infants and 7.2% were infertile. 129 subjects, (12.3%), had positive pcr tests. statistically, there was no significant relationship between subjects, reproductive and personal histories of the subjects with the test results.conclusion: based on the estimated prevalence, it seems that chlamydial infection is prevalent in the studied population. in populations with prevalences higher than 4%, screening programs are recommended, so that chlamydia screening can be considered as a part of health care prog-rams in iran to reduce the burden of the disease.< pan>


Keywords: Chlamydia trachomatis, Prevalence, Women, Iran, Urine, Polymerase chain reaction, Restriction fragment length polymorphism


To cite this article:


References

  1. Duncan B, Hart G. Sexuality and health: the hidden costs of screening for Chlamydia Trachomatis. BMJ. 1999;318:931-33   [PubMed]
  2. Cates W Jr, Wasserheit JN. Genital Chlamydial infec-tions: epidemicology and reproductive sequeale. Am J Obstet Gynecol. 1991;164:1771-81   [PubMed]
  3. Gerbase AC, Rowley JT, Heymann DH, Berkley SF, Piot P. Global prevalence and incidence estimates of selected curable STDs. Sex Transm Infect. 1998;74 (Suppl 1):12-6   [PubMed]
  4. Stamm W E, Jones R B, Batteiger B E. Chlamydia trachomatis (Trachoma, prinatal infections, Lympho-granuloma venereum and other genital infections. Prin-ciples and practice of infectious diseases, Mandell G L, Dolin R, and Bennette J E (Editors) 6th Edition, Pub-lished by Elsevier Churchill Livingstone, Philadelphia. 2005;pp:2239-51
  5. Chiang D T, Tan E I, Baldam A. Incidence of Chlamy-dia infection among asymptomatic women pesented for routine papanicolaou smear: experience in South-Wes-tern Victoria, Australia. Rural Remote Health. 2006;6 (3):633   [Abstract]
  6. Stanczak J J, Majchrzak M J, Stanczak G P. Modern diagnostics of Chlamydia trachomatis infections. Med Wieku Rozwoj. 2005;9(1):9-20   [PubMed]
  7. Bakken I J, Bratt H, Skjeldestad F E, Nordbo S A. Detection of Chlamydia trachomatis in urine, vulval and cervical swabs. Tidsskr Nor Laegeforen. 2005;125 (12):1629-30   [PubMed]
  8. Bakken I J, Skjeldestad F E, Ovreness T, Nordbo S A, Storvold G. Chlamydia infections and sexual behavior among young women. Tidsskr Nor Laegeforen. 2004; 124(12):1633-5   [PubMed]
  9. Ghazal-Aswad S, Badrinath P, Osman N, Abdul-Khaliq S, Mc Ilvenny S, Sidky I. Prevalence of Chlamydia tra-chomatis infection among women in a Middle Eastern community. BMC Womens Health. 2004;27:4(1):3   [PubMed]
  10. Fallah F, Kazemi B, Goudarzi H, Badami N, Doostdar F, Ehteda A. Detection of Chlamydia trachomatis from urine specimens by PCR in women with cervicitis. Iran J Public Health. 2005;34(2):20-26   [Abstract]
  11. Badami N, Salari M H. Rate of Chlamydia tracho-matis, Mycoplasma hominis and Ureaplasma urealy-ticum in infertile females and control group. Iran J Public Health. 2001;30(1-2):57-60   [Abstract]
  12. Salari M H, Badami N. The rate of Chlamydia tracho-matis, mycoplasma hominis and ureaplasma urealyti-cum in females with habitual abortion and its compare-son with control group. Acta Medica Iranica. 2002;40 (1-2):79-82   [Abstract]
  13. Zaeimi Yazdi J, Khorramizadeh M R, Badami N, Kazemi B, Aminharati F, Eftekhar Z, et al. Compara-tive assessment of chlamydia trachomatis infection in Iranian women with cervicitis: A cross-sectional study. Iran J Public Health. 2006;35(2):69-75   [PubMed]
  14. حاجيا مسعود. استاندارد طلايي در تشخيص آزمايشگاهي عفونتهاي كلاميديايي. مجله علمي دانشگاه علوم پزشكي كردستان. سال 5 (1379)، شماره 17، صفحات 49-41
  15. جدي تهراني محمود. روشهاي تشخيصي كلاميديا تراكوماتيس. فصلنامه باروري وناباروري. سال1 (1378)، شماره 1، صفحات 43-36   [Abstract]
  16. Zenilman J M, Miller W C, Gaydos C, Rogers S M, Turner C F. LCR testing for Gonorrhea and Chlamydia in population surveys and other screenings of lows prevalence populations: coping with decreased positive predictive value. Sex Transm Infect. 2003;79:94-97   [PubMed]
  17. Shalepo K, Savicheva A, Shipitsyna E, Unemo M, Domeika M. Diagnosis of Chlamydia trachomatis in Russia-in-house PCR assays may be effective but overall optimization and quality assurance are urgently needed. APMIS. 2006;114(7-8):500-7   [PubMed]
  18. Chen M Y, Donovan B. Changes in testing methods for genital Chlamydia trachomatis in New South Wales, Australia, 1999 to 2002. Sex Health. 2005;2(4): 251-3   [PubMed]
  19. Coble B I, Nordahl-Akesson E, Vinnerberg A, Kihls-trom E. Urine-based testing for Chlamydia trachomatis using polymerase chain reaction, leucocyte esterase and urethral and cervical smears. Scand J Clin Lab Invest. 2006;66(4):269-77   [PubMed]
  20. Scholes D, Stergachis A, Heidrich F E, Andrilla H, Holmes K K, Stamm W E. Prevention of pelvic infla-mmatory disease by screening for cervical Chlamydia infection. N Engl J Med. 1996;334-1362-6   [PubMed]
  21. Kamwendo F, Forslin L, Bodin I, Danielsson D. Decreasing incidences of Gonorrhoea and Chlamydia-associated acute pelvic inflammatory disease. A 25 year study from urban area of central Sweden. Sex Transm Dis. 1996;23:384-91   [PubMed]
  22. Claas H C, Melchers W J, De Bruijn I H, de Graaf M, Van Dijk W C, Lindeman J, et al. Detection of Chla-mydia trachomatis in clinical specimens by the poly-merase chain reaction. Eur J Clin Microbiol Infect Dis. 1990;9(12):864-868   [PubMed]
  23. Centers for Disease Control and Prevention (CDC). Chlamydia screening among sexually active young female enrollees of health plans-United States, 1999-2001. MMWR Morb Mortal Wkly Rep. 2004;53(42): 983-5   [PubMed]
  24. Rassjo E B, Kambugu F, Tumwesigye M N, Tenywa T, Darj E. Prevalence of sexually transmitted infections among adolescents in Kampala, Uganda, and theore-tical models for improving syndromic management. J Adolesc Health. 2006;38(3):213-21   [PubMed]
  25. Levidiotou S, Vrioni G, Papadogeorgaki H, Avdeliodi K, Kada H, Kaparos G, et al. Chlamydia trachomatis infections in Greece: first prevalence study using nucleic acid amplification tests. Eur J Clin Microbiol Infect Dis. 2005;24(3):207-13   [PubMed]
  26. Chen X S, Yin Y P, Chen L P, Thuy N T, Zhang G Y, Shi M Q, et al. Sexually transmitted infections among pregnant women attending an antenatal clinic in Fu-zhou, China. Sex Transm Dis. 2006;33(5):296-301   [PubMed]
  27. Fatholah Zadeh B, Mir Salehian A, Kazemi B, Arsha-di H, Poor Akbari B. Detection of Chlamydia tracho-matis and Neisseria gonorrhea by PCR and multiplex PCR from non-invasive genitourinary specimen of patients with urethritis. J Fac Med. 2004;62(6):449-56
  28. Van Bergen J, Gotz H M, Richardus J H, Hoebe C J, Broer J, Coenen A J, PILOT CT study group. Preva-lence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: results from the first national population based study in the Netherlands. Sex Transm Infect. 2005;81:17-23   [PubMed]
  29. Sylvan S P, Von Krogh G, Tiveljung A, Siwerth B M, Henriksson L, Noren L, et al. Screening and geno-typing of genital Chlamydia trachomatis in urine speci-mens from male and female clients of youth-health centers in Stockholm County. Sex Transm Dis. 2002; 29(7):379-86   [PubMed]
  30. Honey E, Augood C, Templeton A, Russell I, Paavo-nen J, Mardh P A, et al. Cost effectiveness of screening for chlamydia trachomatic: A review of published stu-dies. Sex Transm Infect. 2002;78(6):406-12   [PubMed]
  31. Genc M, Mardh P A. A cost-effectiveness analysis of screening and treating for Chlamydia trachomatis infection in asymptomatic women. Ann Intern Med. 1996;124(Pt 1):1-7   [PubMed]
  32. Paavonen J, Puolakkainen M, Paukku M, Sintonen H. Cost-benefit analysis of first-void urine Chlamydia trachomatis screening programme. Obstet Gynaecol. 1998;92:292-8   [PubMed]

COPE
SID
NLM
AJMB
IJBMLE
IJBMLE

Home | About Us | Current Issue | Past Issues | Submit a Manuscript | Instructions for Authors | Subscribe | Search | Contact Us

"Journal of Reproduction & Infertility" is owned, published, and managed by Avicenna Research Institute .
Creative Commons License

This work is licensed under a Creative Commons Attribution –NonCommercial 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Journal of Reproductoin and Infertility (JRI) is a member of COMMITTEE ON PUBLICATION ETHICS . Verify here .

©2024 - eISSN : 2251-676X, ISSN : 2228-5482, For any comments and questions please contact us.